Sign inJoin waitlistJoin the waitlist

PJ

Preetesh Jain

Physician · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine

Credentials: · · · · ·

History

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
2026–Present

University of Texas M D Anderson Cancer Center
2017–2020
Internal Medicine
University of Texas Health Science Center at Houston
2012–2015
Doctor of Medicine
2008–2012

Research

Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
Blood · 2015 · First of 11 authors · 297 citations
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials
The Lancet Haematology · 2015 · 259 citations
TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes
Cancer · 2016 · 226 citations

Hagop Kantarjian
47 papers
ZE
Zeev Estrov
45 papers
SO
Susan O'Brien
43 papers
Jorge Cortes
37 papers
LW
Luhua Wang
35 papers
William Wierda
34 papers
Rashmi Kanagal-Shamanna
29 papers
Alessandra Ferrajoli
28 papers
Elias Jabbour
28 papers
GB
Gautam Borthakur
27 papers
Jan Burger
25 papers
MK
Michael Keating
25 papers

Clinical trials

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2026–2030
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Principal investigator · Recruiting · Phase 2
M.D. Anderson Cancer Center
2023–2027
A Pilot "Window-3" Study of Acalabrutinib Plus Rituximab Followed by Brexucabtagene Autoleucel Therapy in Patients With Previously Untreated High-risk Mantle Cell Lymphoma
Principal investigator · Active not recruiting · Early phase 1
M.D. Anderson Cancer Center
2022–2027